Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
tafluprost (zioptan) (2 trials)
Glaucoma (Phase 4)
Glaucoma, Open-Angle (Phase 4)
Hypertension (Phase 4)
Ocular Hypertension (Phase 4)
Trials (2 total)
Trial APIs (1 total)